| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 |
| filingDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49196843895b2b2cb3109fed2d079bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b762123313be866e6a2654699a1b8df6 |
| publicationDate |
2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210127389-A |
| titleOfInvention |
Novel Synthtic Method for gaylussacin derivatives |
| abstract |
The present invention relates to a novel synthesis method of a gaylusacin derivative, and the like. The synthesis process of the present invention is a relatively short synthesis process, and each synthesis step is simple, so it can be applied to mass synthesis through an optimization process. As the step consists of a simple extraction and washing process without a chromatography process that is difficult to apply to mass synthesis, it is expected that the required amount for the preclinical/clinical stage can be secured in a short time with high purity. |
| priorityDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |